OncoCyte Corporation (OCX)

OncoCyte Revenue

OncoCyte had revenue of $115.00K in the quarter ending September 30, 2024, a decrease of -73.19%. This brings the company's revenue in the last twelve months to $709.00K, down -51.54% year-over-year. In the year 2023, OncoCyte had annual revenue of $1.50M with 56.89% growth.

• Revenue (ttm): $709.00K
• Revenue Growth: -51.54%
• P/S Ratio: 41.83
• Revenue / Employee: $15,413
• Employees: 46
• Market Cap: 46.30M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.50M	545.00K	56.89%
Dec 31, 2022	958.00K	-1.24M	-56.41%
Dec 31, 2021	2.20M	982.00K	80.76%
Dec 31, 2020	1.22M	-	-
Dec 31, 2019	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.